Open AccessTargeting of the diabetes prevention program leads to substantial benefits when capacity is constrained
Author(s) -
Natalia Olchanski,
David van Klaveren,
Joshua T. Cohen,
John B. Wong,
Robin Ruthazer,
David M. Kent
Publication year - 2021
Publication title -
acta diabetologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.141
H-Index - 67
eISSN - 1432-5233
pISSN - 0940-5429
DOI - 10.1007/s00592-021-01672-3
Subject(s) - diabetes mellitus , medicine , intensive care medicine , endocrinology
Approximately 84 million people in the USA have pre-diabetes, but only a fraction of them receive proven effective therapies to prevent type 2 diabetes. We estimated the value of prioritizing individuals at highest risk of progression to diabetes for treatment, compared to non-targeted treatment of individuals meeting inclusion criteria for the Diabetes Prevention Program (DPP).